Qube Research & Technologies LTD Relay Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.9 - $8.02 $111,038 - $150,936	18,820 Added 13.69%	156,254 $1.02 Million
Q1 2024 May 14, 2024	BUY	$7.5 - $12.07 $768,540 - $1.24 Million	102,472 Added 293.1%	137,434 $1.14 Million
Q4 2023 Feb 13, 2024	BUY	$6.01 - $11.48 $210,121 - $401,363	34,962 New	34,962 $384,000
Q2 2023 Aug 14, 2023	SELL	$9.99 - $18.27 $232,786 - $425,727	-23,302 Reduced 58.14%	16,777 $210,000
Q1 2023 May 15, 2023	SELL	$15.0 - $22.76 $37,845 - $57,423	-2,523 Reduced 5.92%	40,079 $660,000
Q4 2022 Feb 14, 2023	BUY	$14.16 - $24.02 $603,244 - $1.02 Million	42,602 New	42,602 $636,000
Q2 2022 Aug 15, 2022	BUY	$13.31 - $34.88 $791,732 - $2.07 Million	59,484 New	59,484 $996,000

203

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $535M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.